Streetbeat News

Analyst Ratings

GE

GEHC

Citi has initiated coverage on GE HealthCare Technologies Inc (NASDAQ:GEHC) with a Buy rating and a price target of $82. GEHC was spun off from General Electric (NYSE:GE) in January 2023, with GE retaining a 19.9% stake, later reduced to 13.5%. In 2022, GEHC reported sales of over $18 billion. GEHC shares are currently down 0.78% at $65.77.

Portfolio Pulse from Vandana Singh

September 19, 2023 | 5:36 pm

TXG

Canaccord Genuity analyst Kyle Mikson has reiterated a 'Buy' rating on 10x Genomics (NASDAQ:TXG) and maintained a price target of $70.

Portfolio Pulse from Benzinga Newsdesk

September 19, 2023 | 5:25 pm

NSTG

Canaccord Genuity analyst Kyle Mikson has reiterated a 'Buy' rating on NanoString Technologies (NASDAQ:NSTG) and maintained a price target of $10.

Portfolio Pulse from Benzinga Newsdesk

September 19, 2023 | 5:23 pm

SMPL

Morgan Stanley analyst Pamela Kaufman has upgraded The Simply Good Foods Company (NASDAQ:SMPL) from Equal Weight to Overweight and raised the price target from $37 to $40. The analyst sees an attractive buying opportunity following the stock's -11% pullback YTD. The company's participation in the high growth active nutrition category, above-average topline growth outlook, and potential to turn Atkins around are among the reasons for the upgrade.

Portfolio Pulse from Shivani Kumaresan

September 19, 2023 | 5:20 pm

SNX

Stifel analyst Matthew Sheerin reiterated a Buy rating on TD SYNNEX Corporation (SNX), raising the price target to $120 from $110. The company is expected to release its Q3 results on September 26, 2023. The analyst expects sales and adjusted EPS estimates of $14.037 billion and $2.49, respectively. The sales estimate reflects an 8.6% y/y decline, driven by declines in Americas and EMEA. However, advanced solutions and digital transformation initiatives are expected to offset this weakness.

Portfolio Pulse from Nabaparna Bhattacharya

September 19, 2023 | 5:18 pm

LGND

Ligand Pharmaceuticals has entered into a merger agreement with Primrose Bio, making its subsidiary, Pelican Technology Holdings, a wholly owned subsidiary of Primrose Bio. Ligand retains commercial royalties related to Pelican Expression Technology and will own 49.9% of Primrose Bio. Ligand has also updated its annual guidance, increasing adjusted EPS guidance and modifying revenue guidance.

Portfolio Pulse from Vandana Singh

September 19, 2023 | 5:16 pm

LCID

MBGYY

RIVN

TSLA

A new survey from S&P Global reveals that Tesla Inc (NASDAQ:TSLA) has a high customer loyalty rate, with 59.9% of Model S owners and 72.8% of Model 3 owners buying another Tesla vehicle. However, some Tesla owners are moving on to other brands, with the most popular choices being Lucid Air from Lucid Group Inc (NASDAQ:LCID), Rivian R1T from Rivian Automotive Inc (NASDAQ:RIVN), and Mercedes-Benz EQS from Mercedes-Benz ADR (OTC:MBGYY). The upcoming release of Tesla's Cybertruck could potentially increase its customer loyalty.

Portfolio Pulse from Chris Katje

September 19, 2023 | 5:12 pm

SBUX

TD Cowen analyst Andrew M. Charles has downgraded Starbucks Corp (NASDAQ:SBUX) from Outperform to Market Perform and lowered the price target from $117 to $107. The downgrade is due to increasing concerns about Starbucks' performance in China, which is expected to account for 16% of 2025E EBIT. The analyst sees the risk that China headwinds are likely to get stronger rather than weaker, and highlighted low-priced competition that is gaining share, with aggressive discounts that are poised to persist for the next 2+ years.

Portfolio Pulse from Shivani Kumaresan

September 19, 2023 | 5:06 pm

CRM

Salesforce (NYSE:CRM) has seen unusual options activity, with a mix of bullish and bearish trades. The trades range from $160.0 to $320.0, with a total of 2 puts and 8 calls. The price of CRM is currently down -0.53% at $213.86. Several financial institutions have maintained their ratings on Salesforce, with price targets ranging from $220 to $280.

Portfolio Pulse from Benzinga Insights

September 19, 2023 | 5:01 pm

MRVL

A significant bearish stance has been taken on Marvell Tech (NASDAQ:MRVL) by a large investor, as indicated by a large position in options. The overall sentiment of these big-money traders is split between 36% bullish and 63% bearish. The whales have been targeting a price range from $55.0 to $80.0 for Marvell Tech over the last 3 months. The price of MRVL is currently down -1.78% at $53.8. Several analysts have maintained or downgraded their ratings on Marvell Tech with price targets ranging from $65 to $100.

Portfolio Pulse from Benzinga Insights

September 19, 2023 | 5:01 pm